Table 1.
Model | Sample | Marker studied | Studies | Workforce |
G93A-SOD1 cells | SH-Y5Y human NeurobLastoma cells | DMT1 and TfRl | Hadzhieva et al., 2013 | — |
SOD1 G93A mouse | Spinal cord | Iron | Lee et al., 2015 | 4 SOD1 G93A/4 wild-type |
SOD1 G37R mouse | Spinal cord | Iron DMT1, TfR1 ferroportin, ceruloplasmin | Jeong et al., 2009 | 4 SOD1 G37R/ 3 wild-type |
SOD 1G93A rats | Serum | Hepcidin | Halon et al., 2014 | 15 SOD1 G93A/15 wild-type |
ALS patients | Serum | Iron, transferrin, ferritin, TSC | Nadjar et al., 2012 | 629 ALS/297 controls |
Veyrat-Durebex et al., 2014 | 104 ALS/145 controls | |||
Goodall et al., 2008 | 60 ALS/ 44 controls | |||
Ikeda et al., 2012 | 92 ALS/ 92 controls | |||
Ferritin | Qureshi et al., 2008 | 30 ALS/ 30 controls | ||
Su et al., 2015 | 138 ALS/152 controls | |||
Pro-hepcidin | Mitchell et al., 2010 | 30 ALS/ 36 controls | ||
Cerebral cortex | Iron | Oba et al., 1993 | 15 ALS/49 controls | |
Ignjatovic et al., 2013 | 46 ALS/ 26 controls | |||
BCECs, blood capillary endothelial cells; BBB, blood–brain barrier; TfR1, receptor transferrin 1; DMT1, divalent metal ion transporter 1.